v3.25.3
Net Loss per Share (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Potential Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share

The Company’s potential common stock equivalents that have been excluded from the computation of diluted net loss per share for all periods presented because of their antidilutive effect consisted of the following:

 

 

Nine Months Ended
September 30,

 

 

 

2025

 

 

2024

 

Outstanding stock options

 

 

968,732

 

 

 

850,094

 

Non-vested restricted stock units

 

 

8,434

 

 

 

29,153

 

Common stock warrants

 

 

742,726

 

 

 

742,726

 

 

 

 

1,719,892

 

 

 

1,621,973